Endothelin-1 (ET-1) is a potent vasoconstrictor peptide secreted by endothelial cells. We investigated whether polymorphonuclear neutrophils (PMN) were able to destroy this peptide by enzymatic hydrolysis produced either by the membrane-bound endopeptidase 24.11 or by lysosomal proteinases released in the medium by activated cells. Resting and activated PMN were incubated with 125I-labelled ET-1 and the degradation fragments were analyzed by HPLC. A marked degradation of ET-1 was observed only in the presence of the stimulated cells, leading to the generation of seven radiolabelled peaks. Addition of phosphoramidon had no effect on the appearance of these metabolites, while soybean trypsin inhibitor abolished almost completely the degradation of the peptide, suggesting a role of cathepsin G in ET-1 hydrolysis.
Introduction
Endothelin-1 (ET-1) is a 21-amino acid vasoconstrictor peptide originally isolated from cultured endothelial cells [ 1] . It belongs to a family of vasoactive hormones comprising ET-1, ET-2, ET-3 and the murine vasoactive intestinal contractor (for a review, see Ref. 2) . In addition to its potent contractile effect on vessels, ET-1 exerts other physiological actions such as contraction of airway and intestinal smooth muscles, positive inotropic and chronotropic effects on the myocardium [3] . There is increasing evidence for the involvement of endothelin in human diseases, such as hypertension [4] , and coronary vasospasm [5] .
Injected in rat circulation, ET peptides disappear with a very short half-life [6, 7] . In man, the disappearance curve of perfused endothelin-1 exhibit two half-lives of 1.4 and 35 min, respectively [8] . Mechanisms of the peptide removal include binding to specific receptors, urinary excretion and probably enzymatic inactivation. A role for endopeptidase 24.11 (enkephalinase; neutral endopeptidase; EC 3.4.24.11) (E-24.11), a membrane bound metalloenzyme, has been hypothesized from in vitro data showing degradation of ET-1 by proximal tubular membranes from human kidney [9] and by purified E-24.11 [9, 10, 11] .
Considering the presence of endopeptidase 24.11 at the surface of polymorphonuclear neutrophils (PMN) [12] , we investigated whether this enzyme was able to hydrolyze ET-1 in an in vitro cellular system. Resting and phorbol 12-myristate 13-acetate (PMA) activated PMN were incubated with 125I-labelled ET-1, and the degradation fragments were analyzed by HPLC. Our results indicated that the main inactivator of ET-1 in neutrophils was cathepsin G, a serine proteinase contained in azurophilic granules and released in the pericellular area by activated PMN. No effect of the surface membrane-bound enzyme E-24.11 could be detected.
Materials and Methods

Reagents
125I-labelled ET-1 (specific radioactivity approx. 2000 Ci/mmol) was purchased from Amersham International (Amersham, Buckinghamshire, UK). Purified human leukocyte cathepsin G (specific activity of 52 units/mg protein) and its substrate Suc-AlaAla-Pro-Phe-p-nitroanilide as well as purified human leukocyte elastase (specific activity of 110 units/rag protein), alpha 1-antitrypsin, soybean trypsin inhibitor, phosphoramidon and phorbol 12-myfistate 13-acetate were obtained from Sigma (Sigma, St. Louis, MO, USA). Bestatin and amastatin were purchased from Bachem (BObendorf, Switzerland). Purified human proteinase 3 was a gift of Dr. R. Goldschmeding (Central Laboratory of the Netherlands Red Cross Blood Transfusion Service, Amsterdam, The Netherlands).
Neutrophils preparation and activation
Venous blood from healthy human volunteers was collected in 10 ml heparinized syringes. PMN suspensions were prepared according to Verheugt et al. [ 13 ] . Ceils were finally resuspended in Dulbecco's modified Eagle's medium (DMEM, GIBCO Labo-ratories, Grand Island, NY, USA) without Phenol Red at approx. 2.106 cells/ml. Stimulation of the neutrophils was performed at 37°C by adding PMA at a final concentration of 200 ng/ml.
Elastase and cathepsin G assays
2" 106 PMN were stimulated with PMA for 2 and 4 h and elastase release was measured by an automatic immunoassay using the kit Elastase-PMN Imac from Merck. Cathepsin G concentration was determined by measuring free p-nitroanilide released from the substrate N-Suc-Ala-Ala-Pro-Phe-p-nitroanilide [14] .
ET-1 incubation and HPLC fractionation of the cleavage products
125I-ET-1 (about 20,000 cpm per assay) was first incubated for different time intervals at 37 ° C in the presence of PMN (activated or not by PMA) in a final volume of 1 ml. Reaction was stopped by adding trifluoroacetic acid (TFA) at a final concentration of 1 ~o and by a centrifugation at 2500 g for 15 min at room temperature. The resulting supernatant was analysed by HPLC (see below). In a second series of experiments, 125I-ET-1 (about 10,000 cpm per assay) was incubated in the presence of purified leukocyte enzymes (cathepsins G, B and D, elastase, proteinase 3), at a concentration of 8/ag/ml, or endopeptidase 24.11 at a concentration of 0.4/tg/ml (final volume of 100 /~1). Reaction was stopped by adding TFA. 125I-radiolabelled ET-1 and its metabolites were separated by reverse-phase HPLC on/~Bondapak C18 columns (Waters-Millipore, Brussels, Belgium) using TFA 0.09~o. A linear acetonitrile gradient from 10~ to 34~o was applied over 24 min and was followed by a plateau at 34 ~o (during 26 min) at 1 ml/min flow rate. Fractions of 1 ml were collected and their radioactivity was determined in a gamma-radiation counter (LKB, Brussels, Belgium).
Preparation of ET-1 fragments produced upon incubation with cathepsin G and determination of their amino acid composition
ET-1 (1003 nmol) was incubated for 12 h at 37°C with 15 #g purified cathepsin G in 50 mM Tris-HC1 buffer (pH 7.6), containing 0.1~o Triton X-100. The final volume was 1 ml. The sample was fractionated by HPLC using the same gradient conditions as described above. Peaks corresponding to metabolites were monitored at 214 nm and the natural fluorescence of tryptophan was recorded (excitation 280 nm, emission 360 nm). They were collected and evaporated to dryness under vacuum. Acid hydrolyses were performed with 6 M HCI under vacuum in sealed tubes at 110°C for 24 h in the presence of some phenol crystals in order to prevent tyrosine destruction. Peptide hydrolysates were analyzed on a Beckman model 120C amino acid analyzer according to Spackman et al. [15] .
Results
PMN activation by PMA
After 2 h stimulation of PMN with PMA, cathepsin G concentration was 756 ng/ ml while elastase concentration at the same time was 133 ng/ml.
Incubation of radiolabelled ET-1 with PMN
In a first series of experiments, 125I-labelled ET-1 was incubated with resting PMN. At time 0 of incubation, the ~25I-ET-1 appeared as two peaks in the HPLC profile. One corresponded to oxidized ET-1 (retention time: 36 min) and the other corresponded to non oxidized ET-1 (retention time: 39 min). The presence of oxidized 125I-ET-1 was already observed in a solution of the tracer, indicating that conversion of the Met residue to its sulfone or sulfoxide derivative occurred during the preparation and/or storage conditions of 125I-ET-1. Incubation of 125I-labelled ET-1 with resting PMN for 4 or 6 h at 37°C did not produce a time-dependent degradation; only small radiolabelled peaks were observed (Fig. 1) . On the contrary, incubation of 125I-ET-1 at 37 °C with activated PMN led to the progressive disappearance of the peptide. After 4 h at 37 ° C, the percentage of 125I-ET-1 remaining intact was 33.4 ~o. The chromatographic profile revealed 8 radioactive peaks in addition to oxidized and intact 125I-labelled ET-1. The first one corresponded to free 1251 ( Fig. 2A) . Addition of phosphoramidon to the incubation medium had no effect on the formation of these radiolabelled metabolites (intact ET-I: 37.5~o), whereas addition of alpha-1 antitrypsin (~I-AT, an inhibitor of neutral serine proteinases) resulted in a partial recovery of intact 1251-labelled ET-1 (75.6~o). Finally, addition of soybean trypsin inhibitor (STI, an inhibitor of cathepsin G), abolished the generation of the labelled fragments and increased the recovery of 125I-labelled ET-1 to 87.2~o (Fig. 2B) , suggesting a role of cathepsin G in ET-1 degradation by neutrophils.
HPLC analysis of 125I-ET-1 incubated during 4 h with a crude PMN membrane preparation revealed a pattern of degradation products very similar to that obtained with activated PMN. Addition of STI prevented the generation of any labelled metabolite, indicating a complete blockade of all degradative pathways (data not shown). 
Hydrolysis of radiolabelled ET-I by purified leukocyte enzymes
The in vitro observation of ET-1 hydrolysis by activated PMN suggested the involvement of intracellular proteinases in this process, especially cathepsin G. In order to compare the relative efficiencies of PMN lysosomal enzymes to cleave ~25I-ET-1, the peptide was incubated with purified human leukocyte enzymes: elastase, cathepsins G, B, D and proteinase 3 (Fig. 3) .
We observed that cathepsin G hydrolyzed ~25I-ET-1 at a higher rate than proteinase 3 and elastase, while I/5I-ET-1 was insensitive to the action of cathepsins B and D. The HPLC profile obtained in the presence of cathepsin G (Fig. 4) revealed the generation of two metabolites corresponding to the peaks 4 and 5 produced by stimulated PMN (Fig. 2A) . On the contrary, incubation of 125I-ET-1 with purified proteinase 3 or endopeptidase 24.11 did not lead to the generation of metabolites eluting with retention times similar to those obtained in the presence of stimulated PMN (data not shown). TIME (min) Fig. 4 . HPLC analysis of ~25I-ET-1 fragments produced upon incubation with purified leukocyte cathepsin ~25 G. I-ET-1 (I0,000 cpm per assay) was incubated for 6 min at 37°C with purified leukocyte cathepsin G at a final concentration of 8/~g/ml. The conditions of HPLC separation are described in Materials and Methods.
Hydrolysis of unlabelled ET-1 by cathepsin G
In order to identify the degradation fragments produced by cathepsin G, unlabelled ET-1 was incubated with the enzyme. Six peaks corresponding to hydrolysis products were separated by HPLC (Fig. 5 ). They were collected and submitted to amino acid analysis, Peaks 1, 2, 3 had amino acid compositions compatible with the sequence ET-1 [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] and probably differed from each other by additional cleavages in the disulfidelinked loops (Table I) had a composition identical to that of ET-1 and might differ from the intact substrate by one or more cleavages inside the disulfide-linked loops. Peak 6 was present as a double peak due to the appearance of a metabolite not resolved from ET-1. Therefore, it was not further analyzed.
Discussion
Our experiments show that ET-1 was degraded by activated but not by resting PMN. The main enzyme responsible for cleaving ET-1 was cathepsin G, hydrolyzing among others the HisX6-Leu 17 bond. In our in vitro conditions, endopeptidase 24.11 did not contribute significantly to the catabolism of the peptide.
This neutral metallo-endopeptidase, identical with the 'common acute lymphoblastic leukemia antigen' [ 16] , is located on the cell membrane of neutrophils where it is involved in the breakdown of fMet-Leu-Phe, the major chemotactic peptide produced by Escherichia Coli [12] . Inhibition of the enzyme completely blocks fMLP-mediated chemotaxis [17] . The E-24.11 expression on the surface of neutrophils is downregulated by endocytosis. This process can be induced either by specific antibodies or by PMA [ 18] . In the presence of PMA, the enzymatic activity on the cell surface decreases by 76~o within 5 min [18] . From these data, it is obvious that in our experiments, the use of PMA to stimulate PMN has induced a down-regulation of the enzyme. This could explain the lack of effect of E-24.11 in the degradation of 125I-ET-1. Unlabelled ET-1 (1003 nmol) was incubated for 12 h at 37°C with 15 #g purified cathepsin G. Peaks numbered 1 to 5 (Fig. 5 ) were collected and submiued to amino acid analysis. The deduced number of residues in each molecule is indicated in parentheses; P, residue present but not quantified.
However, incubation of radiolabeUed ET-1 with unstimulated PMN did not generate fragments corresponding to those obtained with purified E-24.11 either (data not shown). The minor peaks detected (Fig. 1) were similar to the fragments produced by the stimulated PMN ( Fig. 2A) . This result is probably due to a non specific release of enzymatic content from dying cells during long incubation periods. Furthermore, a preparation enriched in PMN plasma membranes did not show any clear-cut contribution of E-24.11 to ET-1 hydrolysis (data not shown). The membrane-enriched pellet, as well as stimulated PMN, incubated with radiolabelled E;F-1, generated several peaks. Among them, peaks 4 and 5 ( Fig. 2A) corresponded to fragments produced by purified cathepsin G (Fig. 4) . This serine proteinase is contained in azurophilic granules together with other hydrolases such as elastase and proteinase 3 [ 19] . The kinetics performed with these purified leukocyte enzymes indicated that cathepsin G cleaved radiolabelled ET-1 at a higher rate than proteinase 3 and elastase. Cathepsins B and D, two other neutrophil lysosomal proteinases, had no effect on the peptide (Fig. 3) . Cathepsin G cleaves peptides after an aromatic amino acid and after aliphatic amino acids with large hydrophobic side chains. This specificity is observed in the hydrolysis of the His-Leu bond of ET-1. The cleavage of this bond, generating [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] fragments and the C-terminal pentapeptide (Table I) is sufficient to induce a biological activity loss of ET-1. Indeed, we have previously shown that [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] peptides, resulting from the hydrolysis of ET-1 by endopeptidase 24.11, were devoid of vasoconstrictor effect on isolated rat aortic rings [9] .
In recent studies, PMN were incubated with substance P and bradykinin, two peptides involved in inflammation. The former peptide was catabolized mainly by cathepsin G while the latter was inactivated by endopeptidase 24.11 [20] . The estimated 300 to 3600-fold higher concentration of cathepsin G than that of E-24.11 [20] in neutrophils is thought to be responsible for the prominent enzymatic action of cathepsin G on substance P, although the peptide is a good substrate in vitro for purified E-24.11 [21] . The same hypothesis appears to be true for ET-1. This peptide is also degraded by purified E-24.11 [9] [10] [11] , but is mostly hydrolyzed by cathepsin G when it is incubated with PMN. This breakdown was completely prevented by STI (which has been described as a good inhibitor of cathepsin G [22] ) added to the incubation medium (Fig. 2B) . A previous report showed that PMN enzymes were also able to convert big ET-1 into ET-1 which was subsequently degraded [23] .
Very recently, Patrignani et al. [24] , incubating cultured endothelial cells in the presence of PMN, observed that neutrophil enzymes were responsible for inactivation of ET-1 secreted by the endothelial cells. Resting PMN were uneffective. According to these authors, this ET-1 inactivation process by activated PMN could represent an important regulatory process in vivo. Indeed, in early phases of acute inflammatory reaction, neutrophils adhere to the vascular endothelium adjacent to inflammation foci and become activated by chemotactic agents released at these sites. ET-1 was recently found to stimulate PMN adhesion to endothelial cells in an in vitro model [25] . Proteolytic enzymes released (among which cathepsin G), by inactivating ET-1, might limit this critical step of PMN adhesion to the vascular wall. Further steps like diapedesis and phagocytosis could thus be preferentially triggered.
A similar regulatory mechanism could be hypothesized in glomerular inflammation. Since Zoja et al. reported a possible up-regulation by pro-inflammatory agents of the ET-1 gene expression in human cultured mesangial cells [26] , the contribution of ET peptides to the development of glomerular injury is strongly suggested [27] . ET-1 could act not only as a potent vasoconstrictor of the afferent and efferent glomerular arterioles, but also as a regulator agent of mesanglal cells. Chronic activation of mesangial cells as well as neutrophil activation and adhesion to these cells are well recognized to be implicated in the pathophysiology of human and experimental forms of glomerulonephritis [28] . It is not unlikely, then, that enzymatic degradation of ET-1 might represent an important negative feed-back loop, limiting cellular infiltration and proliferation in the glomerulus.
In the ischemia-reperfusion clinical picture, the neutrophil-ET-1 interaction must be discussed in two parts, following the model described by Korthuis et ai. [29] . During the ischemia period, a massive release of ET-1 by endothelial cells is induced by tissular hypoxia, while the activated PMN attack is modulated by adenosine and increased levels of catecholamines. During reperfusion, ET-1 secretion is enhanced by the classical shear-stress stimulus, whereas superoxide anions and free radicals are produced. These agents are known to be potent stimulators of PMN aggregation, adhesion and activation [30] . Lysosomai content (more particularly cathepsin G)released by de-granulation might be responsible not only for tissular damage but also for modulation of the potentially toxic action of secreted ET-1.
As it has been reported with elastase inactivating tumor necrosis factor-alpha [31 ] , our study suggests a new regulatory role for neutrophil proteinases, that is the inactivation of potent mediators of inflammatory processes.
